TEST:

Portrait Flex assay

"ANGLE plc...is pleased to announce the launch of its Portrait™ Flex CTC assay...The assay is provided as a service from ANGLE's Onc-ADaPT™ GCP-compliant laboratories and conducted by an expert team with over 10 years' experience in CTC analysis...The Portrait Flex assay has an analytical sensitivity...of >93%, and an analytical specificity...of >95% for both epithelial and mesenchymal markers."

"ANGLE plc...is delighted to announce that it has signed a contract with a new customer, Crescendo Biologics Limited...Crescendo will use ANGLE's recently launched Portrait Flex assay in its ongoing Phase 1 clinical trial (NCT04839991) investigating the safety and efficacy of CB307, Crescendo's first-in-class prostate-specific membrane antigen (PSMA) x CD137 half-life extended bispecific, for the treatment of patients with PSMA positive solid tumours."